UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Ruxolitinib versus best available therapy in patients with polycythemia vera: 80-week follow-up from the RESPONSE trial

Haematologica (Roma), 2016-07, Vol.101 (7), p.821-829

2016

Volltextzugriff (PDF)

Efficacy and safety of deferasirox at low and high iron burdens: results from the EPIC magnetic resonance imaging substudy

Annals of hematology, 2013-01, Vol.92 (2), p.211-219

2013

Volltextzugriff (PDF)

Efficacy of Deferasirox for the treatment of iron overload in Chinese thalassaemia major patients: results from a prospective, open-label, multicentre clinical trial

Transfusion medicine (Oxford, England), 2013-12, Vol.23 (6), p.389-396

2013

Volltextzugriff (PDF)

Hematologic responses to deferasirox therapy in transfusion-dependent patients with myelodysplastic syndromes

Haematologica (Roma), 2012-09, Vol.97 (9), p.1364-1371

2012

Volltextzugriff (PDF)

Tailoring iron chelation by iron intake and serum ferritin: the prospective EPIC study of deferasirox in 1744 patients with transfusion-dependent anemias

Haematologica (Roma), 2010-04, Vol.95 (4), p.557-566

2010

Volltextzugriff (PDF)

340 Improvement in haematologic parameters in patients with MDS treated with the iron chelator deferasirox (Exjade®): An EPIC study post-hoc analysis

Leukemia research, 2011, Vol.35, p.S136-S137

2011

Volltextzugriff (PDF)

P140 Reduction in serum ferritin (SF) is associated with improvement in liver transaminase levels during treatment with deferasirox (Exjade®) in ironoverloaded patients with myelodysplastic syndromes (MDS)

Leukemia research, 2009-05, Vol.33, p.S140-S141

2009

Volltextzugriff (PDF)

P141 Efficacy and safety of deferasirox (Exjade®) in chelation-naive and previously chelated patients with transfusion-dependent myelodysplastic syndromes (MDS)

Leukemia research, 2009-05, Vol.33, p.S141-S142

2009

Volltextzugriff (PDF)

Changes in quality of life and disease-related symptoms in patients with polycythemia vera receiving ruxolitinib or standard therapy

European journal of haematology, 2016-08, Vol.97 (2), p.192-200

2016

Volltextzugriff (PDF)

Hematologic responses in patients with aplastic anemia treated with deferasirox: a post hoc analysis from the EPIC study

Haematologica (Roma), 2013-07, Vol.98 (7), p.1045-1048

2013

Volltextzugriff (PDF)

Skeletal-related event (SRE) history, bone metastasis location and number affect SRE risk and patient survival in metastatic breast cancer

European journal of cancer supplements, 2008, Vol.6 (7), p.174-174

2008

Volltextzugriff (PDF)

Local Recurrence After Complete Clinical Response and Watch and Wait in Rectal Cancer After Neoadjuvant Chemoradiation: Impact of Salvage Therapy on Local Disease Control

International journal of radiation oncology, biology, physics, 2014-03, Vol.88 (4), p.822-828

2014

Volltextzugriff (PDF)

The prognostic value of pain scores for clinical outcomes in advanced breast cancer and prostate cancer

Journal of clinical oncology, 2008-05, Vol.26 (15_suppl), p.22120-22120

2008

Volltextzugriff (PDF)

Use of Dermal Substitute Matrices for Coverage of Exposed Limb Vascular Repairs: A Literature Review

Plastic and reconstructive surgery. Global open, 2024-06, Vol.12 (6), p.e5855-e5855

2024

Volltextzugriff (PDF)

Continued improvement in myocardial T2 over two years of deferasirox therapy in -thalassemia major patients with cardiac iron overload

Haematologica (Roma), 2011-01, Vol.96 (1), p.48-54

2011

Volltextzugriff (PDF)

New Strategies in Rectal Cancer

The Surgical clinics of North America, 2017-06, Vol.97 (3), p.587-604

2017

Volltextzugriff (PDF)

Nonoperative Approaches to Rectal Cancer: A Critical Evaluation

Seminars in radiation oncology, 2011-07, Vol.21 (3), p.234-239

2011

Volltextzugriff (PDF)

Optimal Timing for Assessment of Tumor Response to Neoadjuvant Chemoradiation in Patients With Rectal Cancer: Do All Patients Benefit From Waiting Longer Than 6 Weeks?

International journal of radiation oncology, biology, physics, 2012-12, Vol.84 (5), p.1159-1165

2012

Volltextzugriff (PDF)

Peer review report 1 on “Best evidence topic: What is the best management of the appendix-stump in acute appendicitis: Simple ligation or stump invagination?”

International journal of surgery (London, England), 2015, Vol.13, p.S198-S198

Habr-Gama, Angelita, MD, PhD

2015

Volltextzugriff (PDF)

Complete Clinical Response after Neoadjuvant Chemoradiation for Distal Rectal Cancer

Surgical oncology clinics of North America, 2010-10, Vol.19 (4), p.829-845

2010

Volltextzugriff (PDF)

In Reply to Sole and Calvo

International journal of radiation oncology, biology, physics, 2014-07, Vol.89 (4), p.933-934

2014

Volltextzugriff (PDF)

Complete Clinical Response after Neoadjuvant Chemoradiotherapy Managed Nonoperatively Results in Better Anorectal Function When Compared with Other Sphincter-Saving Alternatives for Distal Rectal Cancer

Journal of the American College of Surgeons, 2015-10, Vol.221 (4), p.S29-S30

2015

Volltextzugriff (PDF)

Removable self-expandable plastic stent to treat postphotodynamic therapy esophageal stricture

Gastrointestinal endoscopy, 2009-04, Vol.69 (4), p.e27-e30

2009

Volltextzugriff (PDF)

Nonoperative Management of Rectal Cancer

Hematology/oncology clinics of North America, 2015-02, Vol.29 (1), p.135-151

2015

Volltextzugriff (PDF)

1 – 25 von 121

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(102)
Mit Volltextzugriff
(92)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Humans
(71)
Science & Technology
(64)
Life Sciences & Biomedicine
(62)
Male
(53)
Female
(50)
Surgery
(44)
Middle Aged
(41)
Adult
(37)
Aged
(29)
Gastroenterology & Hepatology
(26)
Biological And Medical Sciences
(23)
Medical Sciences
(23)
Treatment Outcome
(20)
Adolescent
(16)
Rectal Neoplasms - Pathology
(16)
Aged, 80 And Over
(15)
Prospective Studies
(15)
Hematology, Oncology And Palliative Medicine
(14)
Rectal Cancer
(14)
Rectal Neoplasms - Therapy
(12)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Ruxolitinib versus best available therapy in patients with polycythemia vera: 80-week follow-up from the RESPONSE trial

Efficacy and safety of deferasirox at low and high iron burdens: results from the EPIC magnetic resonance imaging substudy

Efficacy of Deferasirox for the treatment of iron overload in Chinese thalassaemia major patients: results from a prospective, open-label, multicentre clinical trial

Hematologic responses to deferasirox therapy in transfusion-dependent patients with myelodysplastic syndromes

Tailoring iron chelation by iron intake and serum ferritin: the prospective EPIC study of deferasirox in 1744 patients with transfusion-dependent anemias

340 Improvement in haematologic parameters in patients with MDS treated with the iron chelator deferasirox (Exjade®): An EPIC study post-hoc analysis

P140 Reduction in serum ferritin (SF) is associated with improvement in liver transaminase levels during treatment with deferasirox (Exjade®) in ironoverloaded patients with myelodysplastic syndromes (MDS)

P141 Efficacy and safety of deferasirox (Exjade®) in chelation-naive and previously chelated patients with transfusion-dependent myelodysplastic syndromes (MDS)

Changes in quality of life and disease-related symptoms in patients with polycythemia vera receiving ruxolitinib or standard therapy

Hematologic responses in patients with aplastic anemia treated with deferasirox: a post hoc analysis from the EPIC study

Skeletal-related event (SRE) history, bone metastasis location and number affect SRE risk and patient survival in metastatic breast cancer

Local Recurrence After Complete Clinical Response and Watch and Wait in Rectal Cancer After Neoadjuvant Chemoradiation: Impact of Salvage Therapy on Local Disease Control

The prognostic value of pain scores for clinical outcomes in advanced breast cancer and prostate cancer

Use of Dermal Substitute Matrices for Coverage of Exposed Limb Vascular Repairs: A Literature Review

Continued improvement in myocardial T2 over two years of deferasirox therapy in -thalassemia major patients with cardiac iron overload

New Strategies in Rectal Cancer

Nonoperative Approaches to Rectal Cancer: A Critical Evaluation

Optimal Timing for Assessment of Tumor Response to Neoadjuvant Chemoradiation in Patients With Rectal Cancer: Do All Patients Benefit From Waiting Longer Than 6 Weeks?

Peer review report 1 on “Best evidence topic: What is the best management of the appendix-stump in acute appendicitis: Simple ligation or stump invagination?”

Complete Clinical Response after Neoadjuvant Chemoradiation for Distal Rectal Cancer

In Reply to Sole and Calvo

Complete Clinical Response after Neoadjuvant Chemoradiotherapy Managed Nonoperatively Results in Better Anorectal Function When Compared with Other Sphincter-Saving Alternatives for Distal Rectal Cancer

Removable self-expandable plastic stent to treat postphotodynamic therapy esophageal stricture

Nonoperative Management of Rectal Cancer

Second St. Gallen European Organisation for Research and Treatment of Cancer Gastrointestinal Cancer Conference: consensus recommendations on controversial issues in the primary treatment of rectal cancer

Suchergebnisse filtern